Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Black Diamond Therapeutics (BDTX) Interest Expenses (2020)

Black Diamond Therapeutics' Interest Expenses history spans 1 years, with the latest figure at $1000.0 for Q2 2020.

  • For Q2 2020, Interest Expenses changed N/A year-over-year to $1000.0; the TTM value through Mar 2021 reached $1000.0, changed N/A, while the annual FY2020 figure was $1000.0, N/A changed from the prior year.
  • Interest Expenses reached $1000.0 in Q2 2020 per BDTX's latest filing.
  • In the past five years, Interest Expenses ranged from a high of $1000.0 in Q2 2020 to a low of $1000.0 in Q2 2020.